Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs-Reference-Cited by-同舟云学术

Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs

Published:2024-03-21 Issue: Volume: Page:
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Risen Sydney¹,Kusick Breonna²,Sharma Sadhana³,Gilberto Vincenzo S.³,Brindley Stephen⁴,Aguilar Mikayla²,Brown Jared M.⁴,McGrath Stephanie²,Chatterjee Anushree³,Moreno Julie A.¹^ORCID,Nagpal Prashant³^ORCID

Affiliation:

1. Environmental & Radiological Health Sciences and Brain Research Center, Colorado State University, Fort Collins, Colorado 80523, United States

2. Department of Clinical Sciences and Brain Research Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, United States

3. Sachi Bio, 685 S Arthur Avenue, Colorado Technology Center, Louisville, Colorado 80027, United States

4. Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States

Funder

Small Business Innovation Research

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.4c00068

Reference32 articles.

1. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases

2. Women and Autoimmune Diseases1

3. Inflammasome activation and innate immunity in Alzheimer's disease

4. NLRP3 inflammasome activation drives tau pathology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model;ACS Pharmacology & Translational Science;2024-08-30

2. Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids;ACS Chemical Neuroscience;2024-07-31

3. Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy;Journal of Neuroinflammation;2024-07-27

4. Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model;ACS Chemical Neuroscience;2024-03-25

5. Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy;2024-02-07